Home-based high-dose tDCS for fibromyalgia: predicting response and comparing brain targets

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two home-based tDCS protocols in fibromyalgia: a high-dose approach and a conventional dose. It also explores a comparison between stimulation targets on the motor cortex (M1) and the dorsolateral prefrontal cortex (DLPFC). The study includes economic analysis to see if the high-dose approach is cost-effective. Participants will be adults diagnosed with fibromyalgia and will continue their usual medications as needed. Outcomes will include clinical response and potential EEG-based predictors of treatment response.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who meet the diagnostic criteria described by the American College of Rheumatology (Wolfe et al., 2016):
* Widespread Pain Index (WPI) ≥7 and Symptom Severity Scale (SSS) score ≥5 or a WPI score of 4-6 and SSS ≥9
* Presence of widespread pain, defined as pain in at least 4 of 5 regions. Jaw, chest, and abdominal pain are not included in the definition of widespread pain.
* Symptoms have been generally present for at least 3 months.
* The diagnosis of fibromyalgia (FM) is valid regardless of other diagnoses. The diagnosis of FM does not exclude the presence of other clinically significant diseases.
* Patients with a stable prescription (or lack thereof) for antidepressant/pharmacological medication and who agree to continue it throughout the study.
* Demonstrate the ability to properly administer home-based tDCS independently or with the assistance of a caregiver.
* Have access to an electronic device with a camera (mobile phone or computer) to allow for monitoring of the intervention and communication with the participant.
* Have the capacity and willingness to commit to the study team for the completion of all phases of the study.
* Volunteer to participate and sign the specific informed consent form for this study.

Exclusion Criteria:

* Presenting with immune system disorders or comorbidities that explain the main symptoms of fibromyalgia: rheumatoid arthritis, lupus, autoimmune, neurological, and oncological disorders.
* Presenting with any uncompensated clinical condition such as ischemic heart disease, kidney disease, or liver disease.
* Presenting with dermatological conditions, such as allergic skin reactions at the electrode sites, psoriasis, etc.
* Any exclusion criteria established by clinical guidelines on non-invasive brain stimulation (Woods et al., 2016):
* Metallic implants or head injuries, any electronic device such as cochlear implants or cardiac pacemakers.
* Brain stimulation within the last 6 months.
* A clinical or family history of epilepsy.
* Having any structural lesion (for example, any structural neurological condition or more subcortical lesions than would be expected for their age, or having suffered a stroke affecting the stimulated area or connected areas) or any other clinically significant abnormality that could affect safety, participation in the study, or confound the interpretation of the study results, as determined by the investigator.
* History of drug or alcohol abuse during the study or in the 3 months prior (except for nicotine).
* Changes in drug treatment in the month prior to starting the trial.
* Awaiting trial or litigation during the trial.
* Pregnancy

Where it's running

• Hospital Clínico Universitario de Valencia
  Valencia, Spain Recruiting

Study contacts

• Study coordinator: Ane Miren Gutiérrez Muto, PhD
• Email: investigacion@ionclinics.com
• Phone: +34960606200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Whole-body Cryotherapy for Fatigue in ME/CFS, Fibromyalgia, Long COVID

  This study tests whether brief, repeated exposure to extreme cold can help reduce fatigue and related symptoms in adults with ME/CFS, fibromyalgia, or Long COVID compared to healthy controls.

  Recruiting Oxford Brookes University · Oxford, Oxon · NCT07874217

• Noninvasive brain stimulation to see if it lowers pain in fibromyalgia

  This study tests whether daily noninvasive brain stimulation can reduce pain and improve quality of life for people with fibromyalgia, using two brain targets and a crossover design.

  Recruiting Carnegie Mellon University · Pittsburgh, Pennsylvania and 1 other locations · NCT07644221

• Dietary strategies to help fibromyalgia in overweight or obese women

  This trial tests whether a very low-calorie ketogenic diet, a Mediterranean diet, or a Mediterranean diet with a probiotic can reduce fibromyalgia symptoms in overweight or obese women.

  Recruiting Universita degli Studi di Genova · Genova, Genova · NCT07517757

• Isokinetic microdose exercise for women with fibromyalgia

  This 8-week program will test whether low-dose isokinetic exercise helps women with fibromyalgia reduce pain, improve strength, and enhance quality of life.

  Recruiting European University Miguel de Cervantes · Valladolid, Valladolid · NCT07483216

• Does hardaliye help fibromyalgia when added to a personalized diet?

  This study tests whether a traditional grape-based drink called hardaliye, used with a personalized diet, can improve symptoms and inflammation in adult women with fibromyalgia.

  Recruiting Hacettepe University · Istanbul, Istanbul · NCT07403929

• Personalized ultrasonic brain stimulation to reduce fibromyalgia symptoms

  This study will test whether personalized low-intensity ultrasound to the brain can reduce pain and other symptoms in adults with fibromyalgia who have not improved after standard medications and physical therapy.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07361328

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.